PIA
BIIB icon

Peachtree Investment Advisors’s Biogen BIIB Stock Holding History

Peachtree Investment Advisors’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-65
Closed -$22K – 325
2014
Q4 		$22K Hold
65
– – 0.01% 257
2014
Q3 		$22K Buy
+65
New +$21.4K 0.01% 262

Other funds holding BIIB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Peachtree Investment Advisors's BIIB Position: Q1 2015 in Review

Peachtree Investment Advisors sold out of Biogen (BIIB) in Q1 2015, closing a stake of 65 shares — an estimated $22K sold.

Peachtree Investment Advisors first reported a position in BIIB in Q3 2014 and held it in 2 quarters. The position peaked at $22K in Q4 2014. 966 funds tracked by Wall St. Rank hold BIIB as of Q1 2015.

  • Peachtree Investment Advisors reported no remaining Biogen position as of Q1 2015 after selling out during the quarter.
  • Peachtree Investment Advisors sold 65 Biogen shares in Q1 2015, an estimated $22K.
  • Peachtree Investment Advisors first reported a position in Biogen in Q3 2014 and held it in 2 quarters.
  • Peachtree Investment Advisors's Biogen position peaked at $22K in Q4 2014.
  • 966 funds tracked by Wall St. Rank held Biogen as of Q1 2015.

Based on Peachtree Investment Advisors's 13F filing for Q1 2015, filed 14 Apr 2015.